Biomutant's strong sales have helped Embracer Group hit a new all-time Q1 high of 3.4 billion SEK ($391 million) and the game was profitable within a week after its launch.
Experiment 101's Biomutant is a big success. The game has sold over 1 million units since launch and managed to break even in less than a month after it's release. Biomutant also helped parent branch THQ Nordic to rake in a strong 180.9 million SEK (+37% year-over-year)
Embracer CEO Lars Wingefors says that this is just the beginning for the game, and the company expects Biomutant to continue long-term sales over time. He also teases a possible Switch and PS5/Series X release. "We're confident that Biomutant will make future revenues and strong sales in the future, and potentially across other platforms"
- Read more: Kingdom Come: Deliverance II made 5x revenue than first game, was #2 best-seller on PlayStation
- Read more: Arc Raiders hits 16 million sales, helps drive record revenue and profits for Nexon
- Read more: Capcom's Devil May Cry TV show helps boost Q1 game sales to 14 million, a hefty 50% increase
The main revenue driver in the quarter was the release of Biomutant from our internal studio Experiment 101. So far, the game has sold more than one million copies. The full investment into development and marketing as well as the acquisition cost for Experiment 101 and the IP, was recouped within a week after launch.
